{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:33:07Z","timestamp":1786984387466,"version":"build-2736575974"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"China Mega-Project for Infectious Disease","award":["2017ZX10103005-005"],"award-info":[{"award-number":["2017ZX10103005-005"]}]},{"name":"National Key Technology R&D Program of China","award":["2017ZX10104001"],"award-info":[{"award-number":["2017ZX10104001"]}]},{"name":"External Cooperation Program of Chinese Academy of Sciences","award":["153211KYSB20160001"],"award-info":[{"award-number":["153211KYSB20160001"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.antiviral.2019.104556","type":"journal-article","created":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T11:50:50Z","timestamp":1562673050000},"page":"104556","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["A cross-reactive human monoclonal antibody targets the conserved H7 antigenic site A from fifth wave H7N9-infected humans"],"prefix":"10.1016","volume":"170","author":[{"given":"Mingxin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingguang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengchan","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunpeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.antiviral.2019.104556_bib1","first-page":"3206","article-title":"Avian influenza A\/(H7N2) outbreak in the United Kingdom","volume":"12","author":"Team","year":"2007","journal-title":"Wkly. Releases"},{"issue":"5","key":"10.1016\/j.antiviral.2019.104556_bib2","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1017\/S0950268813003324","article-title":"Prevalence and control of H7 avian influenza viruses in birds and humans","volume":"142","author":"Abdelwhab","year":"2014","journal-title":"Epidemiol. Infect."},{"issue":"1","key":"10.1016\/j.antiviral.2019.104556_bib3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/jac\/dkg007","article-title":"Early administration of oral oseltamivir increases the benefits of influenza treatment","volume":"51","author":"Aoki","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"issue":"5","key":"10.1016\/j.antiviral.2019.104556_bib4","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s007050050695","article-title":"Phylogenetic analysis of H7 haemagglutinin subtype influenza A viruses","volume":"145","author":"Banks","year":"2000","journal-title":"Arch. Virol."},{"issue":"234","key":"10.1016\/j.antiviral.2019.104556_bib5","doi-asserted-by":"crossref","first-page":"234ra255","DOI":"10.1126\/scitranslmed.3008761","article-title":"A cell culture-derived MF59-adjuvanted pandemic A\/H7N9 vaccine is immunogenic in adults","volume":"6","author":"Bart","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.antiviral.2019.104556_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112302","article-title":"A recommended numbering scheme for influenza a HA subtypes","author":"Burke","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2019.104556_bib7","first-page":"284","article-title":"Centers for disease control and prevention. Update: influenza activity\u2014United States, 2003\u201304 season","volume":"53","author":"CDC","year":"2004","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.antiviral.2019.104556_bib8","first-page":"547","article-title":"Centers for Disease Control and Prevention. Update: influenza activity\u2014United States and worldwide, 2003\u201304 season, and composition of the 2004\u201305 influenza vaccine","volume":"53","author":"CDC","year":"2004","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"8","key":"10.1016\/j.antiviral.2019.104556_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022477","article-title":"Benchmarking and analysis of protein docking performance in Rosetta v3.2","volume":"6","author":"Chaudhury","year":"2011","journal-title":"PLoS One"},{"issue":"6100","key":"10.1016\/j.antiviral.2019.104556_bib10","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1126\/science.1222908","article-title":"Highly conserved protective epitopes on influenza B viruses","volume":"337","author":"Dreyfus","year":"2012","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.antiviral.2019.104556_bib11","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1086\/444390","article-title":"Serological analysis of serum samples from humans exposed to avian H7 influenza viruses in Italy between 1999 and 2003","volume":"192","author":"Fabiani","year":"2005","journal-title":"J. Infect. Dis."},{"issue":"26","key":"10.1016\/j.antiviral.2019.104556_bib12","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1056\/NEJMc1313186","article-title":"A recombinant viruslike particle influenza a (H7N9) vaccine","volume":"369","author":"Fries","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.antiviral.2019.104556_bib13","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMoa1304459","article-title":"Human infection with a novel avian-origin influenza a (H7N9) virus","volume":"368","author":"Gao","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.antiviral.2019.104556_bib14","doi-asserted-by":"crossref","first-page":"8235","DOI":"10.1128\/JVI.01085-13","article-title":"Induction of cross-reactive antibodies to novel H7N9 influenza virus by recombinant Newcastle disease virus expressing a North American lineage H7 subtype hemagglutinin","volume":"87","author":"Goff","year":"2013","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.antiviral.2019.104556_bib15","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.chom.2016.05.014","article-title":"Both neutralizing and non-neutralizing human H7N9 influenza vaccine-induced monoclonal antibodies confer protection","volume":"19","author":"Henry Dunand","year":"2016","journal-title":"Cell Host Microbe"},{"issue":"11","key":"10.1016\/j.antiviral.2019.104556_bib16","doi-asserted-by":"crossref","first-page":"6108","DOI":"10.1073\/pnas.100133697","article-title":"A DNA transfection system for generation of influenza A virus from eight plasmids","volume":"97","author":"Hoffmann","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.antiviral.2019.104556_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41564-018-0303-7","article-title":"Structure-function analysis of neutralizing antibodies to H7N9 influenza from naturally infected humans","author":"Huang","year":"2018","journal-title":"Nat. Microbiol."},{"issue":"3","key":"10.1016\/j.antiviral.2019.104556_bib19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/jama.2015.7916","article-title":"Effect of varying doses of a monovalent H7N9 influenza vaccine with and without AS03 and MF59 adjuvants on immune response: a randomized clinical trial","volume":"314","author":"Jackson","year":"2015","journal-title":"J. Am. Med. Assoc."},{"issue":"0009","key":"10.1016\/j.antiviral.2019.104556_bib20","article-title":"Comparison of several adjuvants for inactivated H7N9 influenza virus vaccine","volume":"17","author":"Jie","year":"2016","journal-title":"Chin. Prev. Med."},{"issue":"8","key":"10.1016\/j.antiviral.2019.104556_bib21","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.3201\/eid2308.170600","article-title":"Human infection with highly pathogenic avian influenza A(H7N9) virus, China","volume":"23","author":"Ke","year":"2017","journal-title":"Emerg. Infect. Dis."},{"issue":"3","key":"10.1016\/j.antiviral.2019.104556_bib22","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.vaccine.2013.11.036","article-title":"One-shot vaccination with an insect cell-derived low-dose influenza A H7 virus-like particle preparation protects mice against H7N9 challenge","volume":"32","author":"Klausberger","year":"2014","journal-title":"Vaccine"},{"issue":"9409","key":"10.1016\/j.antiviral.2019.104556_bib23","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0140-6736(04)15589-X","article-title":"Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in The Netherlands","volume":"363","author":"Koopmans","year":"2004","journal-title":"The Lancet"},{"issue":"8","key":"10.1016\/j.antiviral.2019.104556_bib24","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1128\/JVI.03095-13","article-title":"Divergent H7 immunogens offer protection from H7N9 virus challenge","volume":"88","author":"Krammer","year":"2014","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.antiviral.2019.104556_bib25","doi-asserted-by":"crossref","first-page":"6334","DOI":"10.1128\/JVI.07158-11","article-title":"Human monoclonal antibodies to pandemic 1957 H2N2 and pandemic 1968 H3N2 influenza viruses","volume":"86","author":"Krause","year":"2012","journal-title":"J. Virol."},{"issue":"7417","key":"10.1016\/j.antiviral.2019.104556_bib26","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nature11371","article-title":"Structural and genetic basis for development of broadly neutralizing influenza antibodies","volume":"489","author":"Lingwood","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2019.104556_bib27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jcv.2016.02.018","article-title":"A 3-year follow-up study of the seroprevalence of antibodies to avian influenza A H5, H6, H7 and H10 viruses among the general population of Wuhan, China","volume":"77","author":"Liu","year":"2016","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2019.104556_bib53","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btn341","article-title":"PIGS: automatic prediction of antibody structures","author":"Marcatili","year":"2008","journal-title":"Bioinformatics"},{"key":"10.1016\/j.antiviral.2019.104556_bib28","article-title":"Expression of functional recombinant hemagglutinin and neuraminidase proteins from the novel H7N9 influenza virus using the baculovirus expression system","volume":"81","author":"Margine","year":"2013","journal-title":"J. Vis. Exp."},{"issue":"14","key":"10.1016\/j.antiviral.2019.104556_bib29","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1001\/jama.2014.12854","article-title":"Serological responses to an avian influenza A\/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial","volume":"312","author":"Mulligan","year":"2014","journal-title":"J. Am. Med. Assoc."},{"issue":"18","key":"10.1016\/j.antiviral.2019.104556_bib30","first-page":"2952","article-title":"Outbreak of low pathogenicity H7N3 avian influenza in UK, including associated case of human conjunctivitis","volume":"11","author":"Nguyen-Van-Tam","year":"2006","journal-title":"Wkly. Releases"},{"issue":"1","key":"10.1016\/j.antiviral.2019.104556_bib31","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3390\/ijms12010226","article-title":"Computational docking of antibody-antigen complexes, opportunities and pitfalls illustrated by influenza hemagglutinin","volume":"12","author":"Pedotti","year":"2011","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.antiviral.2019.104556_bib33","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1086\/598989","article-title":"Influenza virus resistance to antiviral agents: a plea for rational use","volume":"48","author":"Poland","year":"2009","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.antiviral.2019.104556_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117108","article-title":"Antibodies to antigenic site A of influenza H7 hemagglutinin provide protection against H7N9 challenge","volume":"10","author":"Schmeisser","year":"2015","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.antiviral.2019.104556_bib35","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1016\/j.celrep.2015.11.063","article-title":"Immunogenic stimulus for germline precursors of antibodies that engage the influenza hemagglutinin receptor-binding site","volume":"13","author":"Schmidt","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.antiviral.2019.104556_bib36","doi-asserted-by":"crossref","first-page":"W363","DOI":"10.1093\/nar\/gki481","article-title":"PatchDock and SymmDock: servers for rigid and symmetric docking","volume":"33","author":"Schneidman-Duhovny","year":"2005","journal-title":"Nucleic Acids Res."},{"issue":"Suppl. l_2","key":"10.1016\/j.antiviral.2019.104556_bib37","first-page":"W233","article-title":"The RosettaDock server for local protein\u2013protein docking","volume":"36","author":"Sergey","year":"2008","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"10.1016\/j.antiviral.2019.104556_bib38","article-title":"Serverification of molecular modeling applications: the Rosetta online server that includes everyone (ROSIE)","volume":"22","author":"Sergey","year":"2013","journal-title":"PLoS One"},{"issue":"45","key":"10.1016\/j.antiviral.2019.104556_bib39","doi-asserted-by":"crossref","first-page":"5442","DOI":"10.1016\/j.vaccine.2016.08.057","article-title":"Passive immunization for influenza through antibody therapies, a review of the pipeline, challenges and potential applications","volume":"34","author":"Sparrow","year":"2016","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.antiviral.2019.104556_bib40","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.tim.2017.06.008","article-title":"Epidemiology, evolution, and pathogenesis of H7N9 influenza viruses in five epidemic waves since 2013 in China","volume":"25","author":"Su","year":"2017","journal-title":"Trends Microbiol."},{"issue":"4","key":"10.1016\/j.antiviral.2019.104556_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005578","article-title":"Broadly-reactive neutralizing and non-neutralizing antibodies directed against the H7 influenza virus hemagglutinin reveal divergent mechanisms of protection","volume":"12","author":"Tan","year":"2016","journal-title":"PLoS Pathog."},{"issue":"4","key":"10.1016\/j.antiviral.2019.104556_bib42","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1172\/JCI85317","article-title":"H7N9 influenza virus neutralizing antibodies that possess few somatic mutations","volume":"126","author":"Thornburg","year":"2016","journal-title":"J. Clin. Investig."},{"issue":"12","key":"10.1016\/j.antiviral.2019.104556_bib43","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.3201\/eid1012.040961","article-title":"Human illness from avian influenza H7N3, British Columbia","volume":"10","author":"Tweed","year":"2004","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.104556_bib44","series-title":"Antigenic and Genetic Characteristics of Zoonotic Influenza Viruses and Development of Candidate Vaccine Viruses for Pandemic Preparedness","author":"WHO","year":"2017"},{"key":"10.1016\/j.antiviral.2019.104556_bib45","series-title":"Human Infection with Avian Influenza A(H7N9) Virus -The Total Number of Fatal Cases Is Published on a Monthly Basis by the China National Health and Family Planning Commission","author":"WHO","year":"2018"},{"key":"10.1016\/j.antiviral.2019.104556_bib46","series-title":"Antigenic and Genetic Characteristics of Zoonotic Influenza Viruses and Development of Candidate Vaccine Viruses for Pandemic Preparedness","first-page":"201902","author":"WHO","year":"2019"},{"issue":"5796","key":"10.1016\/j.antiviral.2019.104556_bib47","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/289373a0","article-title":"Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation","volume":"289","author":"Wiley","year":"1981","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.antiviral.2019.104556_bib48","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.bbrc.2009.09.029","article-title":"Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: implications for evasion of immune responses and design of vaccine immunogens","volume":"390","author":"Xiao","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2019.104556_bib49","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/978-1-59745-554-1_6","article-title":"Construction of a large naive human phage-displayed Fab library through one-step cloning","volume":"525","author":"Zhu","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.antiviral.2019.104556_bib52","doi-asserted-by":"crossref","DOI":"10.1126\/science.1243761","article-title":"Preferential recognition of avian-like receptors in human influenza A H7N9 viruses","author":"Xu","year":"2013","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.antiviral.2019.104556_bib50","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1128\/JVI.80.2.891-899.2006","article-title":"Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies","volume":"80","author":"Zhu","year":"2006","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.antiviral.2019.104556_bib51","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12250-013-3313-x","article-title":"Human monoclonal antibodies as candidate therapeutics against emerging viruses and HIV-1","volume":"28","author":"Zhu","year":"2013","journal-title":"Virol. Sin."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219302669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219302669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:29:59Z","timestamp":1759062599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354219302669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":51,"alternative-id":["S0166354219302669"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104556","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A cross-reactive human monoclonal antibody targets the conserved H7 antigenic site A from fifth wave H7N9-infected humans","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104556","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104556"}}